Works matching IS 01676997 AND DT 2011 AND VI 29 AND IP 3

Results: 16

Pharmacokinetic study of the phase III, randomized, double-blind, multicenter trial (TRIBUTE) of paclitaxel and carboplatin combined with erlotinib or placebo in patients with advanced Non-small Cell Lung Cancer (NSCLC)

Published in:

2011

By:

Tran H;
Zinner R;
Blumenschein G;
Oh Y;
Papadimitrakopoulou V;
Kim E;
Lu C;
Malik M;
Lum B;
Herbst R

Publication type:

Journal Article

ATP chemosensitivity testing of new antitumor duplex drugs linking 3`-C-ethynylycytidine (ECyd) and 2'-deoxy-5-fluorouridine (5-FdU) in comparison to standard cytostatica and combinations thereof.

Published in:

2011

By:

Schott S;
Wallwiener M;
Kootz B;
Seeger H;
Fehm T;
Neubauer H

Publication type:

Journal Article

A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma.

Published in:

2011

By:

Hersh E;
O'Day S;
Powderly J;
Khan K;
Pavlick A;
Cranmer L;
Samlowski W;
Nichol G;
Yellin M;
Weber J

Publication type:

Journal Article

ATP chemosensitivity testing of new antitumor duplex drugs linking 3`-C-ethynylycytidine (ECyd) and 2´-deoxy-5-fluorouridine (5-FdU) in comparison to standard cytostatica and combinations thereof.

Published in:

2011

By:

Schott, Sarah;
Wallwiener, Markus;
Kootz, Beate;
Seeger, Harald;
Fehm, Tanja;
Neubauer, Hans

Publication type:

Report

Hypoxia-targeting by tirapazamine (TPZ) induces preferential growth inhibition of nasopharyngeal carcinoma cells with Chk1/2 activation.

Published in:

Investigational New Drugs, 2011, v. 29, n. 3, p. 401, doi. 10.1007/s10637-009-9356-z

By:

Hong, Bo;
Lui, Vivian;
Hui, Edwin;
Ng, Margaret;
Cheng, Suk-Hang;
Sung, Fion;
Tsang, Chi-Man;
Tsao, Sai-Wah;
Chan, Anthony

Publication type:

Article

Cell death induced by novel fluorinated taxanes in drug-sensitive and drug-resistant cancer cells.

Published in:

Investigational New Drugs, 2011, v. 29, n. 3, p. 411, doi. 10.1007/s10637-009-9368-8

By:

Vobořilová, Jana;
Němcová-Fürstová, Vlasta;
Neubauerová, Jitka;
Ojima, Iwao;
Zanardi, Ilaria;
Gut, Ivan;
Kovář, Jan

Publication type:

Article

Efficacy and safety of sorafenib in a subset of patients with advanced soft tissue sarcoma from a Phase II randomized discontinuation trial.

Published in:

Investigational New Drugs, 2011, v. 29, n. 3, p. 481, doi. 10.1007/s10637-009-9367-9

By:

Pacey, Simon;
Ratain, Mark;
Flaherty, Keith;
Kaye, Stanley;
Cupit, Lisa;
Rowinsky, Eric;
Xia, Chenghua;
O'Dwyer, Peter;
Judson, I.

Publication type:

Article

A novel Chk inhibitor, XL-844, increases human cancer cell radiosensitivity through promotion of mitotic catastrophe.

Published in:

2011

By:

Riesterer, Oliver;
Matsumoto, Fumihiko;
Wang, Li;
Pickett, Jessica;
Molkentine, David;
Giri, Uma;
Milas, Luka;
Raju, Uma

Publication type:

Report

Preclinical investigation of tolerance and antitumour activity of new fluorodeoxyglucose-coupled chlorambucil alkylating agents.

Published in:

Investigational New Drugs, 2011, v. 29, n. 3, p. 424, doi. 10.1007/s10637-009-9371-0

By:

Miot-Noirault, Elisabeth;
Reux, Bastien;
Debiton, Eric;
Madelmont, Jean-Claude;
Chezal, Jean-Michel;
Coudert, Pascal;
Weber, Valérie

Publication type:

Article

Preparation, characterisation and preliminary antitumour activity evaluation of a novel nanoparticulate system based on a cisplatin-hyaluronate complex and N-trimethyl chitosan.

Published in:

Investigational New Drugs, 2011, v. 29, n. 3, p. 443, doi. 10.1007/s10637-009-9373-y

By:

Cafaggi, Sergio;
Russo, Eleonora;
Stefani, Rossana;
Parodi, Brunella;
Caviglioli, Gabriele;
Sillo, Greta;
Bisio, Angela;
Aiello, Cinzia;
Viale, Maurizio

Publication type:

Article

Antiproliferative activity, mechanism of action and oral antitumor activity of CP-4126, a fatty acid derivative of gemcitabine, in in vitro and in vivo tumor models.

Published in:

Investigational New Drugs, 2011, v. 29, n. 3, p. 456, doi. 10.1007/s10637-009-9377-7

By:

Bergman, Andries;
Adema, Auke;
Balzarini, Jan;
Bruheim, Skjalg;
Fichtner, Iduna;
Noordhuis, Paul;
Fodstad, Øystein;
Myhren, Finn;
Sandvold, Marit;
Hendriks, Hans;
Peters, Godefridus

Publication type:

Article

Antitumor efficacy and apoptotic activity of substituted chloroalkyl 1H-benz[de]isoquinoline-1,3-diones: a new class of potential antineoplastic agents.

Published in:

Investigational New Drugs, 2011, v. 29, n. 3, p. 434, doi. 10.1007/s10637-009-9372-z

By:

Mukherjee, Asama;
Hazra, Suva;
Dutta, Sushanta;
Muthiah, Shanmugavel;
Mondhe, Dilip;
Sharma, Parduman;
Singh, Shashank;
Saxena, Ajit;
Qazi, Gulam;
Sanyal, Utpal

Publication type:

Article

A phase I study of ispinesib, a kinesin spindle protein inhibitor, administered weekly for three consecutive weeks of a 28-day cycle in patients with solid tumors.

Published in:

Investigational New Drugs, 2011, v. 29, n. 3, p. 467, doi. 10.1007/s10637-009-9374-x

By:

Burris, Howard;
Jones, Suzanne;
Williams, Daphne;
Kathman, Steven;
Hodge, Jeffrey;
Pandite, Lini;
Ho, Peter;
Boerner, Scott;
LoRusso, Patricia

Publication type:

Article

A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma.

Published in:

Investigational New Drugs, 2011, v. 29, n. 3, p. 489, doi. 10.1007/s10637-009-9376-8

By:

Hersh, Evan;
O'Day, Steven;
Powderly, John;
Khan, Khuda;
Pavlick, Anna;
Cranmer, Lee;
Samlowski, Wolfram;
Nichol, Geoffrey;
Yellin, Michael;
Weber, Jeffrey

Publication type:

Article

Phase I study of 17-allylamino-17 demethoxygeldanamycin, gemcitabine and/or cisplatin in patients with refractory solid tumors.

Published in:

Investigational New Drugs, 2011, v. 29, n. 3, p. 473, doi. 10.1007/s10637-009-9381-y

By:

Hubbard, Joleen;
Erlichman, Charles;
Toft, David;
Qin, Rui;
Stensgard, Bridget;
Felten, Sara;
Ten Eyck, Cynthia;
Batzel, Gretchen;
Ivy, S.;
Haluska, Paul

Publication type:

Article

Pharmacokinetic study of the phase III, randomized, double-blind, multicenter trial (TRIBUTE) of paclitaxel and carboplatin combined with erlotinib or placebo in patients with advanced Non-small Cell Lung Cancer (NSCLC).

Published in:

Investigational New Drugs, 2011, v. 29, n. 3, p. 499, doi. 10.1007/s10637-009-9380-z

By:

Tran, Hai;
Zinner, Ralph;
Blumenschein, George;
Oh, Yun;
Papadimitrakopoulou, Vassiliki;
Kim, Edward;
Lu, Charles;
Malik, Mubashira;
Lum, Bert;
Herbst, Roy

Publication type:

Article